Bay 59-3074

CAS : 406205-74-1

Ref. 3D-GRA20574

Informations sur le produit

• Nom: Bay 59-3074
• Synonymes: 1-Butanesulfonic acid, 4,4,4-trifluoro-, 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl ester, 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl 4,4,4-trifluoro-1-butanesulfonate, Bay 593074
• CAS: 406205-74-1

Description

Bay 59-3074 is a cannabinoid receptor agonist that binds to the CB1 receptor. It has been shown to have activity in animal models of rheumatoid arthritis and osteoarthritis, as well as neuropathic and inflammatory pain. Bay 59-3074 also has anti-inflammatory effects, which may be due to its ability to inhibit cyclooxygenase and lipoxygenase enzymes. Bay 59-3074 has been shown to be effective against symptoms of osteoarthritis in humans at doses of 2.5mg twice daily for 10 weeks. This drug also has a profile that is distinct from other cannabinoids, such as gabapentin or carbamazepine, which are used for the treatment of neuropathic pain. This drug binds with high affinity to the G protein coupled receptor CB1 and inhibits voltage gated calcium channels (VGCC).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 453.35 g/mol
• Formule: C₁₈H₁₃F₆NO₄S
• Degré de pureté: Min. 95%